Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNF14 pseudogene 3 (RNF14P3) is a pseudogene related to the *ring finger protein 14* (RNF14) gene. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations, truncations, or disruptions in coding and regulatory regions[3]. Unlike protein-coding genes, RNF14P3 does **not encode a functional protein**, and there is no evidence in current database searches or literature that it serves as a therapeutic target, disease biomarker, or receptor, nor is it implicated in interacting with drugs or in having biological roles. Pseudogenes may sometimes exert regulatory effects, but there is currently **no specific information available for RNF14P3** regarding any functional or disease associations, molecular interactions, or safety concerns[3]. **Critical clarification**: - RNF14P3 is a **pseudogene**, not the functional gene RNF14[RNF14], and should not be confused with RNF14 (ring finger protein 14), an E3 ubiquitin ligase involved in transcriptional regulation, proteostasis, and disease biology[1][2][4][5][7]. - Information found about RNF14 refers to the functional protein-coding gene and not to pseudogenes such as RNF14P3. - Because pseudogenes generally do not produce active proteins or perform canonical target functions, **RNF14P3 is not considered a therapeutic target** and does not have drug interactions, mechanisms of action, or clinical biomarker status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNF14 pseudogene 3 (RNF14P3).